69 / 84
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 2, March/April 2018
AFRICA
131
2016;
25
(2): 103–112.
http://dx.doi.org/10.1016/j.carpath.2015.09.009.98. Hao X-D, Chen P, Wang Y, Li S-X, Xie L-X. Mitochondrial DNA
copy number but not haplogroup is associated with keratoconus in
Han Chinese population.
Exp Eye Res
2015;
132
: 59–63.
http://dx.doi.org/10.1016/j.exer.2015.01.016.
99. Bersani FS, Morley C, Lindqvist D, Epel ES, Picard M, Yehuda R,
et
al
. Mitochondrial DNA copy number is reduced in male combat veter-
ans with PTSD.
Prog Neuro-Psychoph
2016;
64
: 10–17.
http://dx.doi.org/10.1016/j.pnpbp.2015.06.012.
100. Van Oven M, Kayser M. Updated comprehensive phylogenetic tree of
global human mitochondrial DNA variation.
Hum Mutat
2009;
30
(2):
E386–394. doi: 10.1002/humu.20921.
101. Hudson G, Gomez-Duran A, Wilson IJ, Chinnery PF. Recent mitochon-
drial DNA mutations increase the risk of developing common late-onset
human diseases.
PLoS Genet
2014;
10
(5): e1004369. doi:10.1371/journal.
pgen.1004369.
102. Strauss KA, DuBiner L, Simon M, Zaragoza M, Sengupta PP, Li P,
et
al
. Severity of cardiomyopathy associated with adenine nucleotide trans-
locator-1 deficiency correlates with mtDNA haplogroup.
Proc Natl Acad
Sci USA
2013;
110
: 3453–3458. doi: 10.1073/pnas.1300690110.
103. Mishmar D, Ruiz-Pesini E, Golik P, Macaulay V, Clark AG, Hosseini
S,
et al
. Natural selection shaped regional mtDNA variation in
humans.
Proc Natl Acad Sci USA.
2003;
100
(1): 171–176. doi:10.1073/
pnas.0136972100.
104. Ji F, Sharpley M, Derbeneva O, Alves L, Qian P, Wang Y,
et al
.
Mitochondrial DNA variant associated with Leber hereditary optic
neuropathy and high-altitude Tibetans.
Proc Natl Acad Sci USA
2012;
109
(19): 7391–7396. doi: 10.1086/519394.
105. Wallace DC. Mitochondrial DNA variation in human radiation and
disease.
Cell
2015;
163
(1): 33–38. doi:10.1016/j.cell.2015.08.067.
106. Moilanen J, Finnilä S, Majamaa K. Lineage-specific selection in human
mtDNA: lack of polymorphisms in a segment of MTND5 gene in
haplogroup J.
Molec Biol Evol
2003;
20
: 2132–2142. doi: 10.1093/
molbev/msg230.
107. Elson JL, Turnbull DM, Howell N. Comparative genomics and the
evolution of human mitochondrial DNA: assessing the effects of selec-
tion.
Am J Hum Genet
2004;
74
: 229–238. doi: 10.1086/381505.
108. Amo T, Brand M. Were inefficient mitochondrial haplogroups selected
during migrations of modern humans? A test using modular kinetic
analysis of coupling in mitochondria from cybrid cell lines.
Biochem J
2007;
404
: 345–351. doi:10.1042/bj20061609.
109. Kivisild T, Shen P, Wall DP, Do B, Sung R, Davis K,
et al
. The role of
selection in the evolution of human mitochondrial genomes.
Genetics
2006;
172
: 373–387. doi: 10.1534/genetics.105.043901.
110. Howell N, Howell C, Elson JL. Molecular clock debate: Time depend-
ency of molecular rate estimates for mtDNA: this is not the time for
wishful thinking.
Heredity
2008; 107–108. doi:10.1038/hdy.2008.52.
111. Elson JL, Herrnstadt C, Preston G, Thal L, Morris CM, Edwardson
JA,
et al
. Does the mitochondrial genome play a role in the etiology
of Alzheimer’s disease?
Hum Genet
2006;
119
: 241–254. doi 10.1007/
s00439-005-0123-8.
112. Maruszak A,
Ż
ekanowski C. Mitochondrial dysfunction and
Alzheimer’s disease.
Prog Neuro-Psychoph
2011;
35
(2): 320–330. doi:
10.1016/j.pnpbp.2010.07.004.
113. Crispim D, Canani LH, Gross JL, Tschiedel B, Souto KE, Roisenberg
I. The European-specific mitochondrial cluster J/T could confer an
increased risk of insulin-resistance and type 2 diabetes: an analysis of
the m.4216T
>
C and m.4917A
>
G variants.
Ann Hum Genet
2006;
70
(Pt
4): 488–495. doi: 10.1111/j.1469-1809.2005.00249.x.
114. Li S, Besenbacher S, Li Y, Kristiansen K, Grarup N, Albrechtsen A,
et
al
. Variation and association to diabetes in 2000 full mtDNA sequences
mined from an exome study in a Danish population.
Eur J Hum Genet
2014;
22
: 1040–1045. doi:10.1038/ejhg.2013.282.
115. Chinnery PF, Mowbray C, Patel S, Elson JL, Sampson M, Hitman G,
et al
. Mitochondrial DNA haplogroups and type 2 diabetes: a study of
897 cases and 1010 controls.
J Med Genet
2007;
44
(6): e80.
http://dx.doi.
org/10.1136/jmg.2007.048876.
116. Achilli A, Olivieri A, Pala M, Hooshiar Kashani B, Carossa V, Perego
UA,
et al
. Mitochondrial DNA backgrounds might modulate diabetes
complications rather than T2DM as a whole.
PloS One
2011;
6
(6):
e21029. doi:10.1371/journal.pone.0021029.
117. Flaquer A, Baumbach C, Kriebel J, Meitinger T, Peters A, Waldenberger
M,
et al
. Mitochondrial genetic variants identified to be associated with
BMI in adults.
PLoS One
2014;
9
(8): e105116. doi:10.1371/journal.
pone.0105116.
118. Chinnery PF, Elliott HR, Syed A, Rothwell PM, Oxford vascular study.
Mitochondrial DNA haplogroups and risk of transient ischaemic attack
and ischaemic stroke: a genetic association study.
Lancet Neurol
2010;
9
(5): 498–503. doi: 10.1016/S1474-4422(10)70083-1.
119. Elango S, Govindaraj P, Vishwanadha VP, Reddy G, Tamang R,
Muthusami U,
et al
. Analysis of mitochondrial genome revealed a
rare 50 bp deletion and substitutions in a family with hypertension.
Mitochondrion
2011;
11
: 878–885. doi:10.1016/j.mito.2011.07.002.
120. Govindaraj P, Khanb NA, Rani B, Rani DS, Selvaraj P, Jyothi V,
et al
.
Mitochondrial DNA variations associated with hypertrophic cardio-
myopathy.
Mitochondrion
2014;
16
:65–72.
http://dx.doi.org/10.1016/j.mito.2013.10.006.
121. Salas A, Elson JL. Raising doubts about the pathogenicity of mito-
chondrial DNA mutation m.3308T
>
C in left ventricular hyper-
traveculation/compactation.
Cardiology
2011;
122
(2): 113–115. doi:
10.1159/000339348.
122. Salas A, Elson JL. Mitochondrial DNA as a risk factor for false posi-
tives in case-control association studies.
J Genet Genomics
2015;
42
(4):
169–172.
http://dx.doi.org/10.1016/j.jgg.2015.03.002.123. Samuels DC, Carothers AD, Horton R, Chinnery PF. The power to
detect disease associated with mitochondrial DNA haplogroups.
Am
J Hum Genet
2006;
78
(4): 713–720.
http://dx.doi.org/10.1086/502682.124. Pereira L, Soares P, Radivoiac P, Li B, Samuels DC. Comparing phylog-
eny and the predicted pathogenicity of protein variations reveals equal
purifying selection across the global human mtDNA diversity.
Am J
Hum Genet
2011;
88
(4): 433–439. doi 10.1016/j.ajhg.2011.03.006.
125. Nakagawa Y, Ikegami H, Yamato E, Takekawa K, Fujisawa T, Hamada
Y,
et al
. A new mitochondrial DNA mutation associated with non-
insulin-dependent diabetes mellitus.
Biochim Biophys Res Commun
1995;
209
: 664–668. doi:10.1006/bbrc.1995.1550.
126. López-Gallardo E, Iceta R, Iglesias E, Montoya J, Ruiz-Pesini E.
OXPHOS toxicogenomics and Parkinson’s disease.
Mutat Res Rev
Mutat
2011;
728
(3): 98–106. doi: 10.1016/j.mrrev.2011.06.004.
127. López-Gallardo E, Llobet L, Emperador S, Montoya J, Ruiz-Pesini
E. Effects of tributyltin chloride on cybrids with or without an ATP
synthase pathologic mutation
. Environ Health Perspect
2016;
124
:
1399–1405.
http://dx.doi.org/10.1289/ehp182.128. Thusberg J, Olatubosun A, Vihinen M. Performance of mutation patho-
genicity prediction methods on missense variants.
Hum Mutat
2011;
32
(4): 358–368. doi: 10.1002/humu.21445.
129. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN,
et al
.
Automated inference of molecular mechanisms of disease from amino
acid substitutions.
Bioinformatics
2009;
25
(21): 2744–2750. doi:10.1093/
bioinformatics/btp528.
130. Venter M, Malan L, van Dyk E, Elson JL, van der Westhuizen FH.